These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6277759)

  • 1. The effect of oxidation of the Met27 residue of [125I]monoiodoglucagon on receptor-binding affinity.
    Sonne O; Larsen UD; Markussen J
    Hoppe Seylers Z Physiol Chem; 1982 Jan; 363(1):95-101. PubMed ID: 6277759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of radiochemical purity and tissue binding of labelled insulin prepared by lactoperoxidase and chloramine T iodination.
    Zórad S; Svábová E; Klimes I; Macho L
    Endocrinol Exp; 1985 Dec; 19(4):267-75. PubMed ID: 3910407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodoglucagon. Preparation and characterization.
    Desbuquois B
    Eur J Biochem; 1975 May; 53(2):569-80. PubMed ID: 1140201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, purification by HPLC and characterization of monoiodoglucagon labeled with carrier free 125I: use as glucagon receptor probe.
    Birnbaumer L; Swartz TL; Rojas FJ; Garber AJ
    J Recept Res; 1983; 3(1-2):3-20. PubMed ID: 6304305
    [No Abstract]   [Full Text] [Related]  

  • 5. Receptor binding and cell-mediated metabolism of [125I]monoiodoglucagon by isolated canine hepatocytes.
    Hagopian WA; Tager HS
    J Biol Chem; 1984 Jul; 259(14):8986-93. PubMed ID: 6086619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoiodoglucagon: synthesis, purification by high pressure liquid chromatography, and characteristics as a receptor probe.
    Rojas FJ; Swartz TL; Iyengar R; Garber AJ; Birnbaumer L
    Endocrinology; 1983 Aug; 113(2):711-9. PubMed ID: 6307649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodination of thyroid-stimulating hormone for receptor-binding studies with human thyroid membranes: effects of specific activity and method of iodination.
    Kermode JC; Thompson BD
    J Endocrinol; 1980 Mar; 84(3):439-47. PubMed ID: 6248612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and bioactivity of glucagon, modified at methionine-27.
    Nooijen WJ; Kempen HJ
    Horm Metab Res; 1979 Aug; 11(8):459-63. PubMed ID: 227776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin receptors: a comparison between chloramine-T and lactoperoxidase iodination.
    Kuo-Jang K; Ramirez VD
    J Endocrinol Invest; 1978 Jul; 1(3):233-8. PubMed ID: 229147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an exposure to chloramine-T on the immunoreactivity of glucagon.
    Shima K; Sawazaki N; Tanaka R; Tarui S; Nishikawa M
    Endocrinology; 1975 May; 96(5):1254-60. PubMed ID: 1168132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxidative iodination of epidermal growth factor on its binding and secretion by hepatocytes.
    Marti U; Burwen SJ; Barker ME; Huling S; Feren AM; Jones AL
    J Cell Biochem; 1989 May; 40(1):109-19. PubMed ID: 2787328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatography of 125I-labeled mouse epidermal growth factor radioiodinated by six different methods.
    Kienhuis CB; Heuvel JJ; Ross HA; Foekens JA; Benraad TJ
    Clin Chem; 1992 May; 38(5):681-6. PubMed ID: 1582020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
    Thibault G; Grove KL; Deschepper CF
    Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homogeneous [mono-125I-Tyr10]- and [mono-125I-Tyr13] glucagon.
    Pingoud V
    J Chromatogr; 1985 Aug; 331(1):125-32. PubMed ID: 4044734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical analysis of [131I]- and [125I]human thyroglobulin labels for radioimmunoassay use.
    Schlumberger M; Van Herle AJ
    J Clin Endocrinol Metab; 1982 Mar; 54(3):581-6. PubMed ID: 7056843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor binding of selectively labeled (Tyr-10) and (Tyr-13)-mono-125I-glucagons and competition by homologous 127I-labeled isomers.
    Pingoud V; Thole H
    Biochim Biophys Acta; 1987 Jul; 929(2):182-9. PubMed ID: 3036251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iodination of peptide growth factors: platelet-derived growth factor and fibroblast growth factor.
    Rizzino A; Kazakoff P
    Methods Enzymol; 1991; 198():467-79. PubMed ID: 1649955
    [No Abstract]   [Full Text] [Related]  

  • 18. Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2,3, 4, 25, 27 and/or 29.
    Robberect P; Damien C; Moroder L; Coy DH; Wünsch E; Christophe J
    Regul Pept; 1988 May; 21(1-2):117-28. PubMed ID: 2839870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.
    McKee RL; Pelton JT; Trivedi D; Johnson DG; Coy DH; Sueiras-Diaz J; Hruby VJ
    Biochemistry; 1986 Apr; 25(7):1650-6. PubMed ID: 3011069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of endogenous lactoperoxidase antibodies in a solid-phase immunosorbent radioassay for antibodies to protein hormones.
    Ericsson UB; Larsson I
    Clin Chem; 1984 Nov; 30(11):1836-8. PubMed ID: 6386228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.